Source: Eur Respir J 2015; 46: 16-18
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Cottin Vincent, Wuyts Wim. Insights into idiopathic pulmonary fibrosis in the real world. Eur Respir J 2015; 46: 16-18

Member's Comments

No comment yet.

Related content which might interest you: Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease Source: Eur Respir Rev, 27 (150) 180110; 10.1183/16000617.0110-2018 Year: 2018 PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip Source: ERS Lung Science Conference 2021 Year: 2021 Disease progression in early idiopathic pulmonary fibrosis: Insights from the Australian IPF registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Real life experience with nintedanib in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease Source: Eur Respir J 2016; 48: 26-28 Year: 2016 Real world idiopathic pulmonary fibrosis in the EMPIRE registry Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Progression of idiopathic pulmonary fibrosis (IPF): Lessons from asymmetrical disease Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis Year: 2010 Accelerated ageing in idiopathic pulmonary fibrosis and pulmonary hypertension Source: International Congress 2018 – Accelerated ageing in lungs Year: 2018 Course of disease and cause of death in patients with idiopathic pulmonary fibrosis in Eastern Finland Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis Source: Eur Respir J 2016; 48: 538-552 Year: 2016 Current and future therapeutic approaches in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: 693-703 Year: 2005 Are the gains due to pulmonary rehabilitation in idiopathic pulmonary fibrosis and other interstitial lung diseases the same? Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 Genetics in idiopathic pulmonary fibrosis Source: International Congress 2016 – GR3 Scientific Grand Round: precision medicine Year: 2016 Idiopathic pulmonary fibrosis (IPF): the patient journey Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 What have we learned from basic science studies on idiopathic pulmonary fibrosis? Source: Eur Respir Rev, 28 (153) 190029; 10.1183/16000617.0029-2019 Year: 2019 Changes in the small airways in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 The epidemiologic features and the patterns of medical resource use in idiopathic pulmonary fibrosis (IPF) in Korea Source: International Congress 2015 – IPF: clinical aspects Year: 2015